等待开盘 09-30 09:30:00 美东时间
-0.180
-0.62%
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $29 to $28.
08-08 06:17
Healthstream ( ($HSTM) ) has released its Q2 earnings. Here is a breakdown of t...
08-06 11:59
HealthStream (NASDAQ:HSTM) affirms FY2025 sales outlook from $297.500 million-$303.500 million to $297.500 million-$303.500 million vs $300.236 million estimate.
08-05 04:32
HealthStream (NASDAQ:HSTM) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.15 by 16.13 percent. This is a 12.5 percent increase over earnings of $0.16 per share from the
08-05 04:31
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Cabaletta Bio(CABA)"买入"评级,目标价从23美元升至25美元</p> <p>• 瑞穗:维持Tectonic Therapeutic(TECX)"跑赢大市"评级,目标价从51美元
05-16 08:43
Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $30 to $29.
05-15 20:16
Health care (NYSEARCA:XLV) is the most oversold global sector, according to BofA. The sector was down 6.3% from its 200-day moving average in U.S. dollar terms, followed by energy (XLE) and biotechnol...
05-10 00:31
HealthStream (NASDAQ:HSTM), a leading healthcare technology platform company for workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company's common
05-09 04:34